Similar results were obtained for the cells of other tumor types, including HeLa (cervical cancer) and MDA-MB-231 (breast cancer) cells (S1A and S1B Fig), suggesting that pharmacological VC can inhibit the mTOR pathway in a variety of cancer cells. This evidence concerns the gene MTOR and cervical cancer.